Alzheimer

THE GREAT CHALLENGES OF DEEPTECH (4/4). Every Friday, discover a disruptive innovation that could solve a major problem. This week, Montpellier-based Regenlife uses near-infrared light stimulation to treat concussions, certain neurodegenerative diseases such as Alzheimer’s, and depression. The company is seeking to raise 10 million euros.